CRP and telomere syndrome: Our present study also revealed that elevated CRP level was an independent prognostic factor for cofounder-adjusted DFS in the subgroup with studies have more than 100 samples (HR = 1.73; 95% CI: 1.33–2.27; P < 0.001), which meant that STS patients with elevated CRP level might be more likely to progress with local recurrence or distal metastasis.